Bring your portfolio to life with CSL and these ASX healthcare shares

CSL Limited (ASX:CSL) shares are one of three in the healthcare sector which could bring your portfolio to life…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If your portfolio hasn't been performing to expectations this year then now could be a good time to bring it to life with one of the top healthcare shares listed below.

I believe all three have the potential to provide market-beating returns over the next few years, potentially making them great options today. Here's why:

CSL Limited (ASX: CSL)

If you only have room for one healthcare share in your portfolio, I would choose CSL. I'm a big fan of the biotherapeutics giant due to the quality and strength of its CSL Behring and Seqirus businesses. CSL Behring is the global leader in plasma therapies and Seqirus is the second biggest influenza vaccines company globally. I remain confident that both businesses will grow their earnings strongly over the long term thanks to their leading products and heavy investment in research and development.

Nanosonics Ltd (ASX: NAN)

Nanosonics is the infection control specialist behind the increasingly popular trophon EPR disinfection system for ultrasound probes. This system has been growing its installed base at a rapid rate over the last few years and reached 19,310 units globally earlier this year. The beauty of this is that as the installed base grows, so too do the sales of the consumables that it requires. Pleasingly, whilst this installed base is clearly very large, it is still only a fraction of the global market opportunity estimated to be 120,000 units. Due to the quality of the product and favourable regulatory recommendations, I believe Nanosonics is well-placed to grow its market share materially over the next decade. In addition to this, its sales should be given an additional boost from the launch of several new products targeting unmet needs.

Volpara Health Technologies Ltd (ASX: VHT)

A final healthcare share to consider buying is Volpara. It is a medical technology company which provides software that leverages artificial intelligence imaging algorithms to assist with the early detection of breast cancer. I've been very impressed with its progress over the last few years and particularly its performance in FY 2019. Volpara posted a 78% increase in revenue in FY 2019 thanks to its increasing market share in the United States. At the end of the period its market share had grown by a whopping 120% to 7.1%. Due to the quality of its offering and recent acquisitions, I expect more of the same in FY 2020 and beyond.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited and VOLPARA FPO NZ. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Growth Shares

3 exciting Australian growth shares to buy with $3,000 in August

Analysts think these shares could be top buys for Aussie growth investors.

Read more »

Young woman waiting for job interview.
Growth Shares

Australian job ad volumes declined last month. Are Seek shares a sell?

Should investors seek returns elsewhere?

Read more »

happy investor, share price rise, increase, up
Growth Shares

The best ASX growth shares to buy now

These growth shares have been recommended as buys.

Read more »

A young well-dressed couple at a luxury resort celebrate successful life choices.
Growth Shares

Where to invest $2,500 in ASX shares in August

Let's see which shares are being tipped as buys for next month.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Growth Shares

What to buy now with the ASX at a record high

Analysts think these shares could still rise strongly from current levels.

Read more »

A young man looks at a stylised investment graph superimposed on an exterior office building backdrop.
Growth Shares

Where to invest $10,000 in ASX 200 stocks today

Analysts think these high-quality shares are in the buy zone for investors right now.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Growth Shares

Two ASX industrials shares with buy recommendations

One broker believes these growth shares are set to rise.

Read more »

Man smiling at a laptop because of a rising share price.
Growth Shares

I think these 2 exciting ASX growth shares are buys today

These stocks could deliver big returns.

Read more »